Combined alternating sunitinib and bevacizumab in the management of advanced renal cell carcinoma: A phase I/II trial.
- Resource Type
- Article
- Source
- Journal of Clinical Oncology; 2/21/2023 Supplement, Vol. 41, p665-665, 1p
- Subject
- Language
- ISSN
- 0732183X